Skip to main content
. 2018 Jan 8;2018(1):CD008074. doi: 10.1002/14651858.CD008074.pub2

3.1. Analysis.

Comparison 3 ARIPIPRAZOLE (intramuscular) vs OTHER ANTIPSYCHOTIC: b. OLANZAPINE (intramuscular), Outcome 1 Specific behaviour: 1a. Agitation ‐ clinically important change (PANSS‐ EC reduction ≥ 40% from baseline).